PTGS2 and breast cancer: Cyclooxygenase-2 (COX-2) has been proposed as an additional target for quercetin in angiogenesis inhibition, related to extracellular matrix remodeling [45], thus suggesting a possible preventive use of this compound in COX-2-mediated diseases, such as breast cancer [47].